Hosub Lim

Hosub Lim

Auto-generated profile, based on publicly available information

Hosub Lim

Department of Bionic Machinery Research Institute of AI Robotics Korea Institute of Machinery and Materials Daejeon Republic of Korea

Research Focus & Metrics

Academic Career Length

7Years (2020-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
6 April 2023 in Light: Science & Applications
Verified
Journal Article
Open access
PDF file
SBSoojeong Baek
Soojeong Baek
SPSang Hyun Park
Sang Hyun Park
DODonghak Oh
Donghak Oh
KLKanghee Lee
Kanghee Lee
SLSangha Lee
Sangha Lee
TKTeun-Teun Kim
Teun-Teun Kim
Non-Hermitian degeneracies, also known as exceptional points (EPs), have been the focus of much attention due to their singular eigenvalue surface structure. Nevertheless, as pertaining to a non-Hermitian metasurface platform, the reduction of an eigenspace dimensionality at the EP has been investigated mostly in a passive repetitive manner. Here, we propose an electrical and spectral way of resolving chiral EPs and clarifying the consequences of chiral mode collapsing of a non-Hermitian gated graphene metasurface. More specifically, the measured non-Hermitian Jones matrix in parameter space enables the quantification of nonorthogonality of polarisation eigenstates and half-integer topological charges associated with a chiral EP. Interestingly, the output polarisation state can be made orthogonal to the coalesced polarisation eigenstate of the metasurface, revealing the missing dimension at the chiral EP. In addition, the maximal nonorthogonality at the chiral EP leads to a blocking of one of the cross-polarised transmission pathways and, consequently, the observation of enhanced asymmetric polarisation conversion. We anticipate that electrically controllable non-Hermitian metasurface platforms can serve as an interesting framework for the investigation of rich non-Hermitian polarisation dynamics around chiral EPs.

13 March 2020 in ACS Nano
Verified
Journal Article
Closed access
CHChaejeong Heo
Chaejeong Heo
THTaewoo Ha
Taewoo Ha
CYChunjae You
Chunjae You
THThuy Huynh
Thuy Huynh
HLHosub Lim
Hosub Lim
YLYoung Hee Lee
Young Hee Lee

1 July 2022 in Biomicrofluidics
Verified
Journal Article
Closed access
PDF file
HLHosub Lim
Hosub Lim
JCJunhyuck Chang
Junhyuck Chang
KKKyung-Il Kim
Kyung-Il Kim
YMYoungkwang Moon
Youngkwang Moon
SLSaebom Lee
Saebom Lee
JLJinkee Lee
Jinkee Lee
Systematic evolution of ligands by exponential enrichment (SELEX) is a method that is generally used for developing aptamers, which have arisen the promising alternatives for antibodies. However, conventional SELEX methods have limitations, such as a limited selection of target molecules, time-consuming and complex fabrication processes, and labor-intensive processes, which result in low selection yields. Here, we used (i) graphene oxide (GO)-coated magnetic nanoparticles in the selection process for separation and label-free detection and (ii) a multilayered microfluidic device manufactured using a three-dimensionally printed mold that is equipped with automated control valves to achieve precise fluid flows. The developed on-chip aptamer selection device and GO-coated magnetic nanoparticles were used to screen aptamer candidates for adenosine in eight cycles of the selection process within approximately 2 h for each cycle. Based on results from isothermal titration calorimetry, an aptamer with a dissociation constant of 18.6 ± 1.5 μM was selected. Therefore, the on-chip platform based on GO-coated magnetic nanoparticles provides a novel label-free screening technology for biosensors and micro/nanobiotechnology for achieving high-quality aptamers.

3 July 2025 in Trends in Biotechnology
Verified
Journal Article
Open access
HLHosub Lim
Hosub Lim
SYSubin Yu
Subin Yu
HLHyo Jin Lee
Hyo Jin Lee
SHSang Mee Hwang
Sang Mee Hwang
Dong Ha KimDong Ha Kim
Dong Ha Kim
LLLuke P. Lee
Luke P. Lee
Antenatal corticosteroids are recommended for preterm births to enhance lung maturity; however, the guidelines are based on limited studies. Here, we present a placenta-fetal lung microphysiological analysis platform (MAP) to study how corticosteroids promote fetal lung maturation and determine their optimal concentration with minimal side effects. We create trophoblast-capillary-pneumocyte MAP on chips to analyze the transport of corticosteroids from mother to fetus through the placenta. We assessed surfactant production from the pneumocyte after exposure to different concentrations, types, and durations of corticosteroids in the trophoblast layer. We found the concentrations of corticosteroids over 5 mM reduced trophoblast viability and did not increase the surfactant production from pneumocytes. Our research on placenta-fetal lung MAP provides insight into how corticosteroids improve the production of surfactant from immature pneumocytes as they transition from the placenta and suggests that determining the appropriate dosage of corticosteroids to maximize effectiveness while preventing damage to trophoblasts is crucial.

7 October 2026 in Small Methods
Verified
Journal Article
Open access
DKDonghoon Koo
Donghoon Koo
EKEgor Kokin
Egor Kokin
SBSangyul Baik
Sangyul Baik
CPChanyong Park
Chanyong Park
MKMinji Kim
Minji Kim
HLHosub Lim
Hosub Lim
Microfluidic molecular diagnostic chips are redefining point‐of‐care testing by integrating the entire analytical workflow spanning from sample preparation to result detection into a single, compact platform. This comprehensive review systematically examines five essential functional modules—mixing, fluid actuation, reagent storage, separation, and reaction chambers—that underpin integrated lab‐on‐a‐chip systems. For each module, the underlying physical principles and representative technologies are critically analyzed with respect to performance metrics (e.g., efficiency and throughput) and structural complexity. By elucidating how microscale transport phenomena, including laminar flow control, efficient heat and mass transfer, and precise reagent manipulation, enable the automation of biological assays, this review clarifies the diagnostic capabilities achievable on a chip, including nucleic acid amplification, immunoassays, and label‐free molecular sensing. Emerging trends in modular design, scalable fabrication methods, and intelligent autonomous operation are discussed as critical drivers for next‐generation sample‐to‐answer systems. Overall, this review provides a comprehensive, application‐oriented framework to guide the development of portable, intelligent, and clinically deployable molecular diagnostic platforms.